Palvella Therapeutics (PVLA) Payables (2013 - 2026)
Palvella Therapeutics (PVLA) reported Payables of $5.4 million for Q1 2026, up 22.56% year-over-year from $4.4 million in Q1 2025, and up 18.45% quarter-over-quarter from $4.6 million in Q4 2025.
Palvella Therapeutics (PVLA) Payables (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of Payables data on file, last reported at $5.4 million in Q1 2026.
- Payables for Q1 2026 came in at $5.4 million, up 22.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (up 22.56% YoY), and the FY2025 annual result was $4.6 million, changed 0.2% from the prior year.
- Payables grew to $5.4 million in Q1 2026 per PVLA's latest filing, from $4.6 million in the prior quarter.
- Over five years, Payables peaked at $14.1 million in Q1 2022 and troughed at $801000.0 in Q3 2024.
- A 5-year average of $4.7 million and a median of $4.4 million in 2025 frame the typical range for Payables.
- On a YoY basis, Payables climbed as much as 389.96% in 2024 and fell as far as 87.26% in 2024.
- A 5-year view of Payables shows it stood at $4.2 million in 2022, then tumbled by 77.47% to $936000.0 in 2023, then surged by 389.96% to $4.6 million in 2024, then advanced by 0.2% to $4.6 million in 2025, then climbed by 18.45% to $5.4 million in 2026.
- Business Quant data shows PVLA's Payables at $5.4 million in Q1 2026, $4.6 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - | 5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.44 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 801,000.00 |
| Jun 30, 2024 | 969,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 936,000.00 |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 7.60 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | 3.64 Mn |
| Jun 30, 2022 | 10.79 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 8.61 Mn |
| Sep 30, 2021 | 19.69 Mn |
| Jun 30, 2021 | 2.31 Mn |